Zinzino AB Reports 32 % Revenue Upswing in February 2026
Zinzino AB, the Swedish‑listed direct‑sales firm specializing in functional food, coffee and related accessories, announced on 4 March 2026 that its February 2026 sales increased by 32 % compared with the same month a year earlier. The company’s preliminary sales report, released via a PRNewswire distribution and corroborated by local Swedish financial outlets, details a total group revenue of SEK 286.3 million (up from SEK 216.9 million in February 2025) and a cumulative January‑February revenue of SEK 568.6 million (up 26 % from SEK 450.8 million).
Revenue Drivers
| Region | Feb‑26 MSEK | Feb‑25 MSEK | % Change |
|---|---|---|---|
| Nordics | 22.5 | 24.8 | –9 % |
| Central Europe | 81.8 | 57.4 | +43 % |
| East Europe | 26.2 | 29.0 | –10 % |
| South & West Europe | 50.2 | 37.8 | +33 % |
| Baltics | 8.5 | 8.8 | –3 % |
| North America | 67.5 | 32.5 | +108 % |
| South America | 3.6 | 1.2 | +200 % |
| Asia‑Pacific | 18.6 | 19.7 | –6 % |
| Africa | 2.2 | 1.5 | +47 % |
The sharpest growth appears in North America (+108 % Y/Y) and South America (+200 % Y/Y), reflecting the firm’s expanding footprint in the United States, Canada, and select Latin‑American markets. Central and Western European markets also posted strong gains, while the Nordics and East Europe showed modest declines, aligning with the company’s historical focus on higher‑margin functional‑food segments.
Faun Pharma Contribution
Zinzino’s external‑sales subsidiary, Faun Pharma, recorded SEK 5.2 million in February 2026, up 24 % from SEK 4.2 million a year earlier. Faun Pharma’s sales form a critical part of Zinzino’s broader product portfolio, providing specialized nutraceutical offerings that complement the core functional‑food line.
Market Position
With a market capitalization of SEK 5.54 billion and a price‑to‑earnings ratio of 22.19, Zinzino operates in the consumer discretionary sector, leveraging a direct‑sales model across 15 countries in Europe, North America, South America, Asia‑Pacific, and Africa. Its product mix—balance control, immunity control, weight control, skin care, espresso machines, coffee, tea, and accessories—positions it as a diversified player in the health‑and‑wellness retail landscape.
Forward Outlook
The 32 % jump in February 2026 revenue, coupled with a 26 % rise in cumulative first‑month sales, underscores Zinzino’s capacity to scale its direct‑sales operations and to penetrate new markets. The company’s continued investment in research, development, and manufacturing of functional food is likely to sustain growth momentum, particularly as global demand for wellness‑oriented products persists.
This report draws exclusively on the preliminary sales figures released by Zinzino AB on 4 March 2026 and the accompanying press coverage from reputable financial news sources.
